Health Condition 1: null- This study included patients with end stage renal disease undergoing renal transplant.
Conditions
Interventions
Intervention1: Use of two different doses of ATG in renal transplant patients.: In this randomized study, 40 patients (20 in each group) of renal transplant got induction prophylaxis with either a si
Sponsors
Postgraduate Institute of Medical Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: HLA mismatch between allograft kidney recipient and donor Unrelated live donor Deceased donor
Exclusion criteria
Exclusion criteria: Graft Loss Live related donor Patient undergoing second renal transplant Renal graft biopsy shows calcineurin toxicity Pregnant Females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome will be studied in terms of infection rate, time to reach baseline creatinine levels, graft tenderness, CD3+ counts, delayed graft function, biopsy findings and graft dysfunction between the two groups over a period of 6 months.Timepoint: Postoperative 1 month, 3 month. | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: None | — |
Countries
India
Contacts
Public ContactAshish Sharma
Postgraduate Institute of Medical Education and Research, Chandigarh
Outcome results
None listed